|
[1]
|
Advances in natural medicinal plant-based interventions against hypoxia-related neuroinflammation
Journal of Ethnopharmacology,
2026
DOI:10.1016/j.jep.2026.121161
|
|
|
|
|
[2]
|
Improvement of age-related neurocognitive disorders by Ginkgo biloba extract: neuroprotection in focus
International Journal of Psychiatry in Clinical Practice,
2026
DOI:10.1080/13651501.2026.2617217
|
|
|
|
|
[3]
|
The role of herbal medicine in supporting cognitive dysfunction associated with long COVID: Review
Advances in Integrative Medicine,
2026
DOI:10.1016/j.aimed.2026.100671
|
|
|
|
|
[4]
|
A randomised, placebo-controlled, triple-blind clinical trial to investigate the efficacy of Ginkgo biloba extract EGb 761® in cognitive impairment associated with post COVID-19 syndrome—the EGb COCOS protocol
Frontiers in Human Neuroscience,
2026
DOI:10.3389/fnhum.2026.1658342
|
|
|
|
|
[5]
|
Review article: Improving mitochondrial function: Current therapeutic perspectives in neurodegenerative diseases
Pharmacological Research,
2026
DOI:10.1016/j.phrs.2026.108227
|
|
|
|
|
[6]
|
Understanding the Relevance of Cognitive Impairment in Primary Care Settings: The Emerging Role of a Phytopharmaceutical
South Asian Journal of Geriatric Medicine, Surgery, Palliative Care & Hospice,
2026
DOI:10.4103/SAJoGM.SAJoGM_21_25
|
|
|
|
|
[7]
|
Ginkgo biloba
extract EGb 761 is safe and effective in the treatment of mild dementia – a meta-analysis of patient subgroups in randomised controlled trials
The World Journal of Biological Psychiatry,
2025
DOI:10.1080/15622975.2024.2446830
|
|
|
|
|
[8]
|
Clinical guidelines «Cognitive disorders in the elderly and senile persons»
S.S. Korsakov Journal of Neurology and Psychiatry,
2025
DOI:10.17116/jnevro2025125337
|
|
|
|
|
[9]
|
Overview of Nootropic Agents in South Korea and the Impact of Nutrition on Cognitive Function
Korean Journal of Geriatrics & Gerontology,
2025
DOI:10.15656/kjgg.2025.26.2.51
|
|
|
|
|
[10]
|
Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care
Frontiers in Pharmacology,
2024
DOI:10.3389/fphar.2024.1338235
|
|
|
|
|
[11]
|
Die Rolle von Phytotherapie bei COVID-19-assoziierter Angst und
Depression
Zeitschrift für Phytotherapie,
2024
DOI:10.1055/a-2171-9349
|
|
|
|
|
[12]
|
Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease
Journal of Alzheimer's Disease,
2024
DOI:10.3233/JAD-231372
|
|
|
|
|
[13]
|
The Effect of Ginkgo Biloba Leaf Dropping Pill Combined with Butylphthalide Capsule on Cognitive Dysfunction in Patients after Acute Ischemic Stroke and Its Impact on Serum Cytokines
Journal of Biosciences and Medicines,
2024
DOI:10.4236/jbm.2024.127024
|
|
|
|
|
[14]
|
Patienten mit ersten Anzeichen nachlassender geistiger Leistungsfähigkeit: Was der Hausarzt nicht vergessen sollte
Erfahrungsheilkunde,
2023
DOI:10.1055/a-1997-7091
|
|
|
|
|
[15]
|
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
Neuropsychiatric Disease and Treatment,
2023
DOI:10.2147/NDT.S401231
|
|
|
|
|
[16]
|
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
Scientific Reports,
2023
DOI:10.1038/s41598-023-32515-6
|
|
|
|
|
[17]
|
Critical analysis of ginkgo preparations: comparison of approved drugs and dietary supplements marketed in Germany
Naunyn-Schmiedeberg's Archives of Pharmacology,
2023
DOI:10.1007/s00210-023-02602-6
|
|
|
|
|
[18]
|
Combined treatment with
Ginkgo biloba
extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment
Alzheimer's & Dementia: Translational Research & Clinical Interventions,
2022
DOI:10.1002/trc2.12338
|
|
|
|
|
[19]
|
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
IUBMB Life,
2022
DOI:10.1002/iub.2613
|
|
|
|
|
[20]
|
Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
Zeitschrift für Gerontologie und Geriatrie,
2022
DOI:10.1007/s00391-022-02098-4
|
|
|
|
|
[21]
|
Ginkgo biloba Extract EGb 761® Improves Central Vestibular Vertigo in Patients Undergoing Vestibular Exercises: A Randomised Placebo-Controlled Trial
Neuroscience and Medicine,
2022
DOI:10.4236/nm.2022.133008
|
|
|
|
|
[22]
|
Mental Performance and Sport: Caffeine and Co-consumed Bioactive Ingredients
Sports Medicine,
2022
DOI:10.1007/s40279-022-01796-8
|
|
|
|
|
[23]
|
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
2021
DOI:10.17116/jnevro20211211036
|
|
|
|
|
[24]
|
A Single Dose of Ginkgo biloba Extract Induces Gene Expression of Hypothalamic Anorexigenic Effectors in Male Rats
Brain Sciences,
2021
DOI:10.3390/brainsci11121602
|
|
|
|
|
[25]
|
Strategies for the use of
Ginkgo biloba
extract, EGb 761
®
, in the treatment and management of mild cognitive impairment in Asia: Expert consensus
CNS Neuroscience & Therapeutics,
2021
DOI:10.1111/cns.13536
|
|
|
|
|
[26]
|
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)
Pharmaceuticals,
2021
DOI:10.3390/ph14040305
|
|
|
|
|
[27]
|
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
Frontiers in Pharmacology,
2021
DOI:10.3389/fphar.2021.775034
|
|
|
|
|
[28]
|
Management of mild cognitive impairment (MCI): The need for national and international guidelines
The World Journal of Biological Psychiatry,
2020
DOI:10.1080/15622975.2019.1696473
|
|
|
|
|
[29]
|
Prüfplan für die monozentrische prospektive randomisierte placebokontrollierte doppelblinde Phase-II-Studie zur Exploration protektiver Effekte des Ginkgo-biloba-Spezialextrakts EGb 761® vor einer vorübergehenden Hörschädigung durch Lärm
HNO,
2020
DOI:10.1007/s00106-019-00807-x
|
|
|
|
|
[30]
|
The Effects of Standardized Ginkgo Biloba Extracts (GBE) on Subjective Cognitive Decline (SCD) in Middle-Aged Adults: A Review
Advances in Aging Research,
2020
DOI:10.4236/aar.2020.93005
|
|
|
|
|
[31]
|
Pathology, Prevention and Therapeutics of Neurodegenerative Disease
2019
DOI:10.1007/978-981-13-0944-1_24
|
|
|
|
|
[32]
|
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba
extract, EGb 761®
CNS Neuroscience & Therapeutics,
2019
DOI:10.1111/cns.13095
|
|
|
|
|
[33]
|
Phytochemicals for Improving Aspects of Cognitive Function and Psychological State Potentially Relevant to Sports Performance
Sports Medicine,
2019
DOI:10.1007/s40279-018-1007-0
|
|
|
|
|
[34]
|
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence
Oxidative Medicine and Cellular Longevity,
2019
DOI:10.1155/2019/9695412
|
|
|
|
|
[35]
|
Přehled systematických souhrnů studií: využití extraktu z Ginkgo biloba v léčbě mírného kognitivního poškození a demence
Neurologie pro praxi,
2018
DOI:10.36290/neu.2018.145
|
|
|
|
|
[36]
|
Therapeutic efficacy of the Ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease
The World Journal of Biological Psychiatry,
2017
DOI:10.1080/15622975.2017.1308552
|
|
|
|
|
[37]
|
A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761®
European Archives of Psychiatry and Clinical Neuroscience,
2016
DOI:10.1007/s00406-015-0632-y
|
|
|
|
|
[38]
|
Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment - a randomized double-blind placebo-controlled trial
Human Psychopharmacology: Clinical and Experimental,
2016
DOI:10.1002/hup.2534
|
|
|
|
|
[39]
|
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia
Frontiers in Aging Neuroscience,
2016
DOI:10.3389/fnagi.2016.00276
|
|
|
|
|
[40]
|
Studies in Natural Products Chemistry,
2016
DOI:10.1016/B978-0-444-63932-5.00005-X
|
|
|
|
|
[41]
|
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
The journal of nutrition, health & aging,
2015
DOI:10.1007/s12603-015-0582-0
|
|
|
|
|
[42]
|
Analysing time to event data in dementia prevention trials: The example of the guidage study of EGB761®
The journal of nutrition, health & aging,
2015
DOI:10.1007/s12603-015-0661-2
|
|
|
|
|
[43]
|
Diet and Nutrition in Dementia and Cognitive Decline
2015
DOI:10.1016/B978-0-12-407824-6.00095-1
|
|
|
|
|
[44]
|
Efficacy and safety ofGinkgo bilobaextract EGb 761®in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial
International Journal of Geriatric Psychiatry,
2014
DOI:10.1002/gps.4103
|
|
|
|
|
[45]
|
Evidence and Rational Based Research on Chinese Drugs
2013
DOI:10.1007/978-3-7091-0442-2_11
|
|
|
|
|
[46]
|
Clinical data in early intervention
International Psychogeriatrics,
2012
DOI:10.1017/S1041610212000555
|
|
|
|
|
[47]
|
Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®
International Psychogeriatrics,
2012
DOI:10.1017/S1041610212000567
|
|
|
|